Eloctate IV 3000, manufactured by Sanofi, contains Efflaloctocog alpha (genetically recombination), a recombinant DNA-derived antihemophilic factor for hemophilia A patients. It is available as 3,000 IU 1 bottle with dissolving solution (YJ code: 6343442D7020).
Eloctate IV 3000
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →